Acute Agitation and Aggression Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Acute Agitation and Aggression Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Aug 2019 Transparency Market Research Pharmaceutical245 Pages Price :
$ 5795

Acute Agitation and Aggression Treatment Market - Scope of the Study

Transparency Market Research (TMR) conducted a comprehensive assessment regarding the growth potential of the acute agitation and aggression treatment market, in its latest research report, for the forecast period of 2019-2027. The research report consists of some distinguished insights for stakeholders for them to sustain their position and move to a higher market share. This exclusive research report is intended at providing rare and distinguished insights pertaining to the growth of the acute agitation and aggression treatment market, and offers information regarding the growth opportunities for market players. With the help of the insights mentioned in the research report, stakeholders in the acute agitation and aggression treatment market will be able to gain a brief outlook on its growth trajectory, which can help them in making well-informed strategies for their business growth.

The comprehensive business study analyzes and discusses Porter’s Five Forces, with a latent aim to provide the key growth strategies available in the acute agitation and aggression treatment market during the forecast period. This comprehensive guide provides key insights regarding the competition present in the acute agitation and aggression treatment market by identifying key competitors. This exclusive research report also offers information about the key strategies, financials, and notable developments of the acute agitation and aggression treatment market during the forecast period of 2019-2027. The acute agitation and aggression treatment market assessment has been conducted in terms of value (US$ Mn).

Acute Agitation and Aggression Treatment Market - Segmentation

In order to offer a microscopic as well as macroscopic view of the acute agitation and aggression treatment market, analysts and researchers of this research report have segregated the acute agitation and aggression treatment market on the basis of drug class, route of administration, end user, indication, and region. This exclusive business study also analyzes the incremental opportunity present in the acute agitation and aggression treatment market during the forecast period.

Acute Agitation and Aggression Treatment Market - Key Questions Answered

This comprehensive research report analyzes and answers key questions concerning the growth of the acute agitation and aggression treatment market for the forecast period of 2019-2027. Some of the key questions answered in this research report are:

  • What are the recent developments and key market shifts expected to be witnessed in the acute agitation and aggression treatment market during the forecast period?
  • What are the key winning imperatives for leading and prominent players operating in the acute agitation and aggression treatment market?
  • What are the key trends propelling the growth of the acute agitation and aggression treatment market?
  • Which end user will exert a strong influence on the acute agitation and aggression treatment market?

Acute Agitation and Aggression Treatment Market - Research Methodology

The research undertaken by Transparency Market Research (TMR) analysts consists of a robust approach in order to cull key insights regarding the growth of the acute agitation and aggression market for the forecast period of 2019-2027. Interviews as well as discussions with leading opinion leaders, market heads, vendors, distributors, industry experts, and key players were carried out in order to conduct primary research. In addition to this, our analysts also conducted a thorough secondary study of marketing collaterals, industry associations, company websites, and government statistics.

1 Preface
1.1 Market Definition and Scope
1.2 Market Segmentation
1.3 Key Research Objectives
1.4 Research Highlights 
2 Assumptions and Acronyms
3 Research Methodology
4 Executive Summary
5 Market Overview

5.1 Product Overview
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increase in incidence of dementia in geriatric population 
5.2.1.2 Rise in burden of mental illness and increase in agitation in patients
5.2.1.3 Economic burden of schizophrenia
5.2.1.4 Focus on creating awareness about agitation and aggression
5.2.1.5 Surge in prescriptions of anti-psychotics
5.2.2 Restraints
5.2.2.1 Social stigma associated with mental illness
5.2.2.2 Preference for non-pharmacological interventions
5.2.3 Opportunities
5.2.3.1 Ongoing research on the development of novel treatment for agitation
5.2.3.2 Agitation and Aggression - Unmet clinical needs
5.2.4 Global Acute Agitation and Aggression Treatment Market Revenue (US$ Mn) Forecast, 2017–2027
5.2.5 Global Acute Agitation and Aggression Treatment Market Outlook
5.2.6 Pipeline Analysis
5.2.7 Regulatory Scenario Assessment
5.2.8 Treatment Protocol
5.2.9 Key Strategies adopted by Market Players
5.2.10 Mental Health Spending
5.2.11 Healthcare Industry Overview
6 Global Acute Agitation and Aggression Treatment Market Analysis, by Drug Class
6.1 Introduction
6.2 Market Value Share Analysis, by Drug Class 
6.3 Market Value Forecast, by Drug Class, 2017–2027
6.3.1 First-generation Anti-psychotics
6.3.2 Second-generation Anti-psychotics
6.3.3 Benzodiazepines
6.3.4 Others
6.4 Market Attractiveness, by Drug Class
7 Global Acute Agitation and Aggression Treatment Market Analysis, by Route of Administration
7.1 Introduction
7.2 Market Value Share Analysis, by Route of Administration
7.3 Market Value Forecast, by Route of Administration, 2017–2027
7.3.1 Oral
7.3.2 Intramuscular
7.3.3 Others
7.4 Market Attractiveness, by Route of Administration
8 Global Acute Agitation and Aggression Treatment Market Analysis, by Indication
8.1 Introduction
8.2 Market Value Share Analysis, by Indication
8.3 Market Value Forecast, by Indication, 2017–2027
8.3.1 Schizophrenia
8.3.2 Dementia
8.3.3 Bipolar Disorders
8.3.4 Depression
8.3.5 Alcohol Withdrawal
8.3.6 Drug-induced Agitation and Aggression
8.3.7 Others
8.4 Market Attractiveness, by Indication
9 Global Acute Agitation and Aggression Treatment Market Analysis, by End-user
9.1 Introduction
9.2 Market Value Share Analysis, by End-user
9.3 Market Value Forecast, by End-user, 2017–2027
9.3.1 Hospitals & Ambulatory Surgical Centers
9.3.1.1 Intensive Care Unit
9.3.1.2 Emergency Department
9.3.2 Psychiatric Care Facilities
9.3.3 Others
9.4 Market Attractiveness, by End-user
10 Global Acute Agitation and Aggression Treatment Market Analysis, by Region
10.1 Regional Outlook
10.2 Global Scenario
10.3 Introduction
10.4 Market Value Share Analysis, by Region
10.4.1 North America
10.4.2 Europe
10.4.3 Latin America
10.4.4 Asia Pacific 
10.4.5 Middle East & Africa
10.5 Market Attractiveness Analysis, by Region
11 North America Acute Agitation and Aggression Treatment Market Analysis
11.1 Key Findings
11.2 Market Value Forecast, by Country, 2017–2027
11.2.1 U.S.
11.2.2 Canada
11.3 Market Value Forecast, by Drug Class, 2017–2027
11.3.1 First-generation Anti-psychotics
11.3.2 Second-generation Anti-psychotics
11.3.3 Benzodiazepines
11.3.4 Others
11.4 Market Value Forecast, by Route of Administration, 2017–2027
11.4.1 Oral
11.4.2 Intramuscular
11.4.3 Others
11.5 Market Value Forecast, by Indication, 2017–2027
11.5.1 Schizophrenia
11.5.2 Dementia
11.5.3 Bipolar Disorders
11.5.4 Depression
11.5.5 Alcohol Withdrawal
11.5.6 Drug-induced Agitation and Aggression
11.5.7 Others
11.6 Market Value Forecast, by End-user, 2017–2027
11.6.1 Hospitals & Ambulatory Surgical Centers
11.6.1.1 Intensive Care Unit
11.6.1.2 Emergency Department
11.6.2 Psychiatric Care Facilities
11.6.3 Others
11.7 Market Attractiveness Analysis
11.7.1 By Country
11.7.2 By Drug Class
11.7.3 By Route of Administration
11.7.4 By Indication
11.7.5 By End-user
12 Europe Acute Agitation and Aggression Treatment Market Analysis
12.1 Key Findings
12.2 Market Value Forecast, by Country/Sub-region, 2017–2027
12.2.1 U.K.
12.2.2 Germany
12.2.3 France
12.2.4 Italy
12.2.5 Spain
12.2.6 Rest of Europe
12.3 Market Value Forecast, by Drug Class, 2017–2027
12.3.1 First-generation Anti-psychotics
12.3.2 Second-generation Anti-psychotics
12.3.3 Benzodiazepines
12.3.4 Others
12.4 Market Value Forecast, by Route of Administration, 2017–2027
12.4.1 Oral
12.4.2 Intramuscular
12.4.3 Others
12.5 Market Value Forecast, by Indication, 2017–2027
12.5.1 Schizophrenia
12.5.2 Dementia
12.5.3 Bipolar Disorders
12.5.4 Depression
12.5.5 Alcohol Withdrawal
12.5.6 Drug-induced Agitation and Aggression
12.5.7 Others
12.6 Market Value Forecast, by End-user, 2017–2027
12.6.1 Hospitals & Ambulatory Surgical Centers
12.6.1.1 Intensive Care Unit
12.6.1.2 Emergency Department
12.6.2 Psychiatric Care Facilities
12.6.3 Others
12.7 Market Attractiveness Analysis
12.7.1 By Country/Sub-region
12.7.2 By Drug Class
12.7.3 By Route of Administration
12.7.4 By Indication
12.7.5 By End-user
13 Asia Pacific Acute Agitation and Aggression Treatment Market Analysis
13.1 Key Findings
13.2 Market Value Forecast, by Country/Sub-region, 2017–2027
13.2.1 China
13.2.2 Japan
13.2.3 India
13.2.4 Australia
13.2.5 Rest of Asia Pacific
13.3 Market Value Forecast, by Drug Class, 2017–2027
13.3.1 First-generation Anti-psychotics
13.3.2 Second-generation Anti-psychotics
13.3.3 Benzodiazepines
13.3.4 Others
13.4 Market Value Forecast, by Route of Administration, 2017–2027
13.4.1 Oral
13.4.2 Intramuscular
13.4.3 Others
13.5 Market Value Forecast, by Indication, 2017–2027
13.5.1 Schizophrenia
13.5.2 Dementia
13.5.3 Bipolar Disorders
13.5.4 Depression
13.5.5 Alcohol Withdrawal
13.5.6 Drug-induced Agitation and Aggression
13.5.7 Others
13.6 Market Value Forecast, by End-user, 2017–2027
13.6.1 Hospitals & Ambulatory Surgical Centers
13.6.1.1 Intensive Care Unit
13.6.1.2 Emergency Department
13.6.2 Psychiatric Care Facilities
13.6.3 Others
13.7 Market Attractiveness Analysis
13.7.1 By Country/Sub-region
13.7.2 By Drug Class
13.7.3 By Route of Administration
13.7.4 By Indication
13.7.5 By End-user
14 Latin America Acute Agitation and Aggression Treatment Market Analysis
14.1 Key Findings
14.2 Market Value Forecast, by Country/Sub-region, 2017–2027
14.2.1 Brazil
14.2.2 Mexico
14.2.3 Rest of Latin America
14.3 Market Value Forecast, by Drug Class, 2017–2027
14.3.1 First-generation Anti-psychotics
14.3.2 Second-generation Anti-psychotics
14.3.3 Benzodiazepines
14.3.4 Others
14.4 Market Value Forecast, by Route of Administration, 2017–2027
14.4.1 Oral
14.4.2 Intramuscular
14.4.3 Others
14.5 Market Value Forecast, by Indication, 2017–2027
14.5.1 Schizophrenia
14.5.2 Dementia
14.5.3 Bipolar Disorders
14.5.4 Depression
14.5.5 Alcohol Withdrawal
14.5.6 Drug-induced Agitation and Aggression
14.5.7 Others
14.6 Market Value Forecast, by End-user, 2017–2027
14.6.1 Hospitals & Ambulatory Surgical Centers
14.6.1.1 Intensive Care Unit
14.6.1.2 Emergency Department
14.6.2 Psychiatric Care Facilities
14.6.3 Others
14.7 Market Attractiveness Analysis
14.7.1 By Country/Sub-region
14.7.2 By Drug Class
14.7.3 By Route of Administration
14.7.4 By Indication
14.7.5 By End-user
15 Middle East & Africa Acute Agitation and Aggression Treatment Market Analysis
15.1 Key Findings
15.2 Market Value Forecast, by Country/Sub-region, 2017–2027
15.2.1 GCC Countries
15.2.2 Israel
15.2.3 South Africa
15.2.4 Rest of Middle East & Africa
15.3 Market Value Forecast, by Drug Class, 2017–2027
15.3.1 First-generation Anti-psychotics
15.3.2 Second-generation Anti-psychotics
15.3.3 Benzodiazepines
15.3.4 Others
15.4 Market Value Forecast, by Route of Administration, 2017–2027
15.4.1 Oral
15.4.2 Intramuscular
15.4.3 Others
15.5 Market Value Forecast, by Indication, 2017–2027
15.5.1 Schizophrenia
15.5.2 Dementia
15.5.3 Bipolar Disorders
15.5.4 Depression
15.5.5 Alcohol Withdrawal
15.5.6 Drug-induced Agitation and Aggression
15.5.7 Others
15.6 Market Value Forecast, by End-user, 2017–2027
15.6.1 Hospitals & Ambulatory Surgical Centers
15.6.1.1 Intensive Care Unit
15.6.1.2 Emergency Department
15.6.2 Psychiatric Care Facilities
15.6.3 Others
15.7 Market Attractiveness Analysis
15.7.1 By Country/Sub-region
15.7.2 By Drug Class
15.7.3 By Route of Administration
15.7.4 By Indication
15.7.5 By End-user
16 Company Profiles
16.1 Eli Lilly and Company 
16.1.1 Company Overview (Headquarters, Business Segments, Employee Strength)
16.1.2 Financial Overview
16.1.3 SWOT Analysis
16.1.4 Strategic Overview
16.2 Pfizer, Inc. 
16.2.1 Company Overview (Headquarters, Business Segments, Employee Strength)
16.2.2 Financial Overview
16.2.3 SWOT Analysis
16.2.4 Strategic Overview
16.3 Ono Pharmaceutical Co., Ltd. 
16.3.1 Company Overview (Headquarters, Business Segments, Employee Strength)
16.3.2 Financial Overview
16.3.3 SWOT Analysis
16.3.4 Strategic Overview
16.4 Otsuka Holdings Co., Ltd. 
16.4.1 Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.2 Financial Overview
16.4.3 SWOT Analysis
16.4.4 Strategic Overview
16.5 GlaxoSmithKline plc
16.5.1 Company Overview (Headquarters, Business Segments, Employee Strength)
16.5.2 Financial Overview
16.5.3 SWOT Analysis
16.5.4 Strategic Overview
16.6 Bristol-Myers Squibb Company 
16.6.1 Company Overview (Headquarters, Business Segments, Employee Strength)
16.6.2 Financial Overview
16.6.3 SWOT Analysis
16.6.4 Strategic Overview
16.7 Janssen Biotech, Inc. (Johnson & Johnson)
16.7.1 Company Overview (Headquarters, Business Segments, Employee Strength)
16.7.2 Financial Overview
16.7.3 SWOT Analysis
16.7.4 Strategic Overview
16.8 H. Lundbeck A/S 
16.8.1 Company Overview (Headquarters, Business Segments, Employee Strength)
16.8.2 Financial Overview
16.8.3 SWOT Analysis
16.8.4 Strategic Overview

List of Table

List of Tables

Table 01: Pipeline Analysis – Acute Agitation and Aggression Treatment
Table 02: Principle difference between U.S., EU and India 
Table 03: Regulatory Scenario Assessment - Administrative Requirements 
Table 04: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 05: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 06: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Indication, 2016–2026
Table 07: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 08: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Hospitals & Ambulatory Surgical Centers, 2017–2027
Table 09: Global Acute Agitation and Aggression Treatment Market Size (US$ Mn) Forecast, by Region, 2017–2027
Table 10: North America Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 11: North America Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
Table 12: North America Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Intramuscular Benzodiazepines, 2017–2027
Table 13: North America Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 14: North America Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 15: North America Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 16: North America Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Hospitals & Ambulatory Surgical Centers, 2017–2027
Table 17: Europe Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 18: Europe Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
Table 19: Europe Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 20: Europe Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 21: Europe Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 22: Europe Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Hospitals & Ambulatory Surgical Centers, 2017–2027
Table 23: Asia Pacific Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 24: Asia Pacific Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
Table 25: Asia Pacific Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 26: Asia Pacific Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 27: Asia Pacific Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 28: Asia Pacific Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Hospitals & Ambulatory Surgical Centers, 2017–2027
Table 29: Latin America Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 30: Latin America Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
Table 31: Latin America Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 32: Latin America Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 33: Latin America Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 34: Latin America Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Hospitals & Ambulatory Surgical Centers, 2017–2027
Table 35: Middle East & Africa Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 36: Middle East & Africa Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Drug Class, 2017–2027
Table 37: Middle East & Africa Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
Table 38: Middle East & Africa Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 39: Middle East & Africa Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 40: Middle East & Africa Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, by Hospitals & Ambulatory Surgical Centers, 2017–2027

List of Chart

List of Figures

Figure 01: Global Acute Agitation and Aggression Treatment Market Snapshot
Figure 02: Global Acute Agitation and Aggression Treatment Market Value (US$ Bn) and Distribution (%), by Region, 2019 and 2027
Figure 03: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, 2017–2027
Figure 04: Global Acute Agitation and Aggression Treatment Market Value Share (%), by Drug Class, 2018
Figure 05: Global Acute Agitation and Aggression Treatment Market Value Share (%), by Route of Administration, 2018
Figure 06: Global Acute Agitation and Aggression Treatment Market Value Share (%), by Indication, 2018
Figure 07: Global Acute Agitation and Aggression Treatment Market Value Share (%), by End-user, 2018
Figure 08: Global Acute Agitation and Aggression Treatment Market Value Share (%), by Region, 2018
Figure 09: Regulatory Approval Process - U.S.
Figure 10: Regulatory Approval Process - Europe
Figure 11: Regulatory Approval Process - India
Figure 12: Acute Agitation and Aggression - Treatment Protocol 
Figure 13: Key Strategies - Otsuka Holdings
Figure 14: Key Strategies - H. Lundbeck A/S 
Figure 15: Mental Health Spending as a proportion of Total Health Spending
Figure 16: Global Acute Agitation and Aggression Treatment Market Value Share Analysis, by Drug Class, 2018 and 2027
Figure 17: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by First-generation Anti-psychotics, 2017–2027
Figure 18: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Second-generation Anti-psychotics, 2017–2027
Figure 19: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Benzodiazepines, 2017–2027
Figure 20: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027
Figure 21: Global Acute Agitation and Aggression Treatment Market Attractiveness, by Drug Class, 2019?2027
Figure 22: Global Acute Agitation and Aggression Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 23: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Oral, 2017–2027
Figure 24: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Intramuscular, 2017–2027
Figure 25: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027
Figure 26: Global Acute Agitation and Aggression Treatment Market Attractiveness, by Route of Administration, 2019?2027
Figure 27: Global Acute Agitation and Aggression Treatment Market Value Share Analysis, by Indication, 2018 and 2027
Figure 28: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Schizophrenia, 2017–2027
Figure 29: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Dementia, 2017–2027
Figure 30: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Bipolar Disorder, 2017–2027
Figure 31: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Depression, 2017–2027
Figure 32: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Drug-induced Agitation and Aggression, 2017–2027
Figure 33: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Alcohol Withdrawal, 2017–2027
Figure 34: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027
Figure 35: Global Acute Agitation and Aggression Treatment Market Attractiveness, by Indication, 2019?2027
Figure 36: Global Acute Agitation and Aggression Treatment Market Value Share Analysis, by End-user, 2018 and 2027
Figure 37: Global Acute Agitation and Aggression Treatment Market Value Share Analysis, by Hospitals & Ambulatory Surgical Centers, 2018 and 2027
Figure 38: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals & Ambulatory Surgical Centers, 2017–2027
Figure 39: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Psychiatric Care Facilities, 2017–2027
Figure 40: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027
Figure 41: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Intensive Care Unit, 2017–2027
Figure 42: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Emergency Department, 2017–2027
Figure 43: Global Acute Agitation and Aggression Treatment Market Attractiveness, by End-user, 2019?2027
Figure 44: Global Acute Agitation and Aggression Treatment Market Attractiveness, by Hospitals & Ambulatory Surgical Centers, 2019?2027
Figure 45: Acute Agitation and Aggression Treatment Market: Regional Outlook
Figure 46: Global Acute Agitation and Aggression Treatment Market Value (US$ Mn) Forecast, 2017–2027
Figure 47: Global Acute Agitation and Aggression Treatment Market Value Share Analysis, by Region, 2018 and 2027
Figure 48: Global Acute Agitation and Aggression Treatment Market Attractiveness, by Region, 2019-2027
Figure 49: North America Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 50: North America Acute Agitation and Aggression Treatment Market Attractiveness Analysis, by Country, 2019–2027
Figure 51: North America Acute Agitation and Aggression Treatment Market Value Share Analysis, by Country, 2018 and 2027
Figure 52: North America Acute Agitation and Aggression Treatment Market Value Share Analysis, by Drug Class, 2018 and 2027
Figure 53: North America Acute Agitation and Aggression Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 54: North America Acute Agitation and Aggression Treatment Market Value Share Analysis, by Indication, 2018 and 2027
Figure 55: North America Acute Agitation and Aggression Treatment Market Value Share Analysis, by End-user, 2018 and 2027
Figure 56: North America Acute Agitation and Aggression Treatment Market Value Share Analysis, by Hospitals & Ambulatory Surgical Centers, 2018 and 2027
Figure 57: North America Acute Agitation and Aggression Treatment Market Attractiveness, by Drug Class, 2019?2027
Figure 58: North America Acute Agitation and Aggression Treatment Market Attractiveness, by Route of Administration, 2019?2027
Figure 59: North America Acute Agitation and Aggression Treatment Market Attractiveness, by Indication, 2019?2027
Figure 60: North America Acute Agitation and Aggression Treatment Market Attractiveness, by End-user, 2019?2027
Figure 61: North America Acute Agitation and Aggression Treatment Market Attractiveness, by Hospitals & Ambulatory Surgical Centers, 2019?2027
Figure 62: Europe Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 63: Europe Acute Agitation and Aggression Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 64: Europe Acute Agitation and Aggression Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 65: Europe Acute Agitation and Aggression Treatment Market Value Share Analysis, by Drug Class, 2018 and 2027
Figure 66: Europe Acute Agitation and Aggression Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 67: Europe Acute Agitation and Aggression Treatment Market Value Share Analysis, by Indication, 2018 and 2027
Figure 68: Europe Acute Agitation and Aggression Treatment Market Value Share Analysis, by End-user, 2018 and 2027
Figure 69: Europe Acute Agitation and Aggression Treatment Market Value Share Analysis, by Hospitals & Ambulatory Surgical Centers, 2018 and 2027
Figure 70: Europe Acute Agitation and Aggression Treatment Market Attractiveness, by Drug Class, 2019?2027
Figure 71: Europe Acute Agitation and Aggression Treatment Market Attractiveness, by Route of Administration, 2019?2027
Figure 72: Europe Acute Agitation and Aggression Treatment Market Attractiveness, by Indication, 2019?2027
Figure 73: Europe Acute Agitation and Aggression Treatment Market Attractiveness, by End-user, 2019?2027
Figure 74: Europe Acute Agitation and Aggression Treatment Market Attractiveness, by Hospitals & Ambulatory Surgical Centers, 2019?2027
Figure 75: Asia Pacific Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 76: Asia Pacific Acute Agitation and Aggression Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 77: Asia Pacific Acute Agitation and Aggression Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 78: Asia Pacific Acute Agitation and Aggression Treatment Market Value Share Analysis, by Drug Class, 2018 and 2027
Figure 79: Asia Pacific Acute Agitation and Aggression Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 80: Asia Pacific Acute Agitation and Aggression Treatment Market Value Share Analysis, by Indication, 2018 and 2027
Figure 81: Asia Pacific Acute Agitation and Aggression Treatment Market Value Share Analysis, by End-user, 2018 and 2027
Figure 82: Asia Pacific Acute Agitation and Aggression Treatment Market Value Share Analysis, by Hospitals & Ambulatory Surgical Centers, 2018 and 2027
Figure 83: Asia Pacific Acute Agitation and Aggression Treatment Market Attractiveness, by Drug Class, 2019?2027
Figure 84: Asia Pacific Acute Agitation and Aggression Treatment Market Attractiveness, by Route of Administration, 2019?2027
Figure 85: Asia Pacific Acute Agitation and Aggression Treatment Market Attractiveness, by Indication, 2019?2027
Figure 86: Asia Pacific Acute Agitation and Aggression Treatment Market Attractiveness, by End-user, 2019?2027
Figure 87: Asia Pacific Acute Agitation and Aggression Treatment Market Attractiveness, by Hospitals & Ambulatory Surgical Centers, 2019?2027
Figure 88: Latin America Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 89: Latin America Acute Agitation and Aggression Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 90: Latin America Acute Agitation and Aggression Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 91: Latin America Acute Agitation and Aggression Treatment Market Value Share Analysis, by Drug Class, 2018 and 2027
Figure 92: Latin America Acute Agitation and Aggression Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 93: Latin America Acute Agitation and Aggression Treatment Market Value Share Analysis, by Indication, 2018 and 2027
Figure 94: Latin America Acute Agitation and Aggression Treatment Market Value Share Analysis, by End-user, 2018 and 2027
Figure 95: Latin America Acute Agitation and Aggression Treatment Market Value Share Analysis, by Hospitals & Ambulatory Surgical Centers, 2018 and 2027
Figure 96: Latin America Acute Agitation and Aggression Treatment Market Attractiveness, by Drug Class, 2019?2027
Figure 97: Latin America Acute Agitation and Aggression Treatment Market Attractiveness, by Route of Administration, 2019?2027
Figure 98: Latin America Acute Agitation and Aggression Treatment Market Attractiveness, by Indication, 2019?2027
Figure 99: Latin America Acute Agitation and Aggression Treatment Market Attractiveness, by End-user, 2019?2027
Figure 100: Latin America Acute Agitation and Aggression Treatment Market Attractiveness, by Hospitals & Ambulatory Surgical Centers, 2019?2027
Figure 101: Middle East & Africa Acute Agitation and Aggression Treatment Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 102: Middle East & Africa Acute Agitation and Aggression Treatment Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 103: Middle East & Africa Acute Agitation and Aggression Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 104: Middle East & Africa Acute Agitation and Aggression Treatment Market Value Share Analysis, by Drug Class, 2018 and 2027
Figure 105: Middle East & Africa Acute Agitation and Aggression Treatment Market Value Share Analysis, by Route of Administration, 2018 and 2027
Figure 106: Middle East & Africa Acute Agitation and Aggression Treatment Market Value Share Analysis, by Indication, 2018 and 2027
Figure 107: Middle East & Africa Acute Agitation and Aggression Treatment Market Value Share Analysis, by End-user, 2018 and 2027
Figure 108: Middle East & Africa Acute Agitation and Aggression Treatment Market Value Share Analysis, by Hospitals & Ambulatory Surgical Centers, 2018 and 2027
Figure 109: Middle East & Africa Acute Agitation and Aggression Treatment Market Attractiveness, by Drug Class, 2019?2027
Figure 110: Middle East & Africa Acute Agitation and Aggression Treatment Market Attractiveness, by Route of Administration, 2019?2027
Figure 111: Middle East & Africa Acute Agitation and Aggression Treatment Market Attractiveness, by Indication, 2019?2027
Figure 112: Middle East & Africa Acute Agitation and Aggression Treatment Market Attractiveness, by End-user, 2019?2027
Figure 113: Middle East & Africa Acute Agitation and Aggression Treatment Market Attractiveness, by Hospitals & Ambulatory Surgical Centers, 2019?2027

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 5795
$ 8795

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top